Incorporated on 18 March 2015 and still active on the Companies House register, Replimune Limited operates from a single address at Innovation Drive in Abingdon. Its registered SIC code 72110 places the company in the field of research and experimental development on biotechnology, positioning it within the UK's applied biosciences sector. The company is registered as a private limited company and holds a Worker (A rating) licence under the Global Business Mobility: Senior or Specialist Worker visa route. That licence indicates Replimune is an approved sponsor for skilled migrants, a signal that it employs senior or specialist staff from outside the UK. The precise number of employees is not published, but the existence of a sponsor licence, together with the nature of biotechnology R&D, points to a small or medium-sized firm with a need for highly qualified scientists and researchers. As is typical for such businesses, the work likely involves laboratory-based investigation and early-stage product development in a therapeutic field, although no specific focus has been disclosed. International operations cannot be confirmed from the available facts; the company may collaborate with academic or commercial partners abroad, but that remains speculative. For job seekers, the key takeaway is that Replimune is an active sponsor-licensed entity, but its scale and specific research targets are not fully public.

Incorporated on 18 March 2015 and still active on the Companies House register, Replimune Limited operates from a single address at Innovation Drive in Abingdon. Its registered SIC code 72110 places the company in the field of research and experimental development on biotechnology, positioning it within the UK's applied biosciences sector. The company is registered as a private limited company and holds a Worker (A rating) licence under the Global Business Mobility: Senior or Specialist Worker visa route. That licence indicates Replimune is an approved sponsor for skilled migrants, a signal that it employs senior or specialist staff from outside the UK. The precise number of employees is not published, but the existence of a sponsor licence, together with the nature of biotechnology R&D, points to a small or medium-sized firm with a need for highly qualified scientists and researchers. As is typical for such businesses, the work likely involves laboratory-based investigation and early-stage product development in a therapeutic field, although no specific focus has been disclosed. International operations cannot be confirmed from the available facts; the company may collaborate with academic or commercial partners abroad, but that remains speculative. For job seekers, the key takeaway is that Replimune is an active sponsor-licensed entity, but its scale and specific research targets are not fully public.